Announcement PDF ASX Release 27th October 2015 RESULTS OF ANNUAL GENERAL MEETING PharmAust Limited (ASX: PAA) today held its Annual General Meeting of Shareholders at Epichem Pty Ltd, Suite 5, 3 Brodie-Hall Drive, Bentley, Western Australia. All resolutions that were put were unanimously passed on a show of hands. The Company notes that Professor David Morris has retired as a director of the Company, effective from the close of the Annual General Meeting and that Professor Morris plans to concentrate on his work at St George Hospital and research work with his foundation. PharmAust Limited Executive Chairman, Dr Roger Aston, commented: "David has been a director of PharmAust since 12 August 2013 and has been a valuable contributor to the Company and the research and development of its three oncology technology platforms. The Board wishes him well in his future endeavours.” In accordance with section 251AA of the Corporations Act, proxy votes exercisable by all proxies validly appointed were: 1 2 3 4 5 Resolution Adoption of Remuneration Report Re-election of Director - Mr Sam Wright Consolidation of capital Approval to issue options to Dr Wayne Best Approval of Additional Placement Capacity Proxy Discretion For Against Abstain * 42,708,704 3,311,775 168,769,842 Nil 212,224,435 212,224,435 2,311,775 2,311,775 254,111 254,111 Nil Nil 44,303,812 1,970,778 168,515,731 Nil 211,224,435 3,311,775 254,111 Nil * Represents 168,515,731 shares held by directors of PharmAust whose votes were excluded from resolutions 1 & 4. Yours sincerely, Sam Wright Director & Company Secretary PharmAust Limited ABN 35 094 006 023 Suite 39, 1 Freshwater Parade, Claremont, Western Australia Tel: 08 6364 0899 Fax: 08 9467 6111 www.pharmaust.com